bioRN M2M Member to Member featuring Cell Signaling Technologies

bioRN M2M Member to Member featuring Cell Signaling Technologies
Go back

Trusting the Signal: Why Reagent Reliability and Data Integrity Are Strategic Biopharma Assets

In our next bioRN Member to Member, we welcome Yannik Nossin from Cell Signaling Technology (CST).

Founded by scientists in 1999, CST is a global provider of research antibodies and reagents, with a strong focus on scientific validation, product quality and data integrity.

Together with Yannik, we’ll explore why reagent reliability matters, how CST approaches antibody validation, and why transparency in scientific data is becoming an increasingly important topic for the life sciences industry.

We’ll also learn how CST supports biotech companies and research institutions beyond supplying reagents – through scientific expertise and collaboration.

Join us for 25 minutes of insights into a topic that affects the reliability of biomedical research and the decisions built upon it.

Grab your coffee or lunch and dial in:

When: 17 November 2026 at 12pm, digital via Zoom

We look forward to welcoming you!

register now

Our latest News

discover more
Diaper Recycling: Progress Even Among the Market Leader

Diaper Recycling: Progress Even Among the Market Leader

Used diapers account for a very large portion of our waste, and to date, no economically viable recycling process has been established. In the Encycling project, the NMI team led by Dr. Anne Zeck and Dr. Simon Straß developed an enzymatic process that was successfully applied to diapers from various manufacturers. Further research was needed […]

read more
From microscopy to AI: Andreas von Deimling shaped modern brain tumor diagnostics in Heidelberg

From microscopy to AI: Andreas von Deimling shaped modern brain tumor diagnostics in Heidelberg

After almost 20 years, Professor Dr. Andreas von Deimling has handed over leadership of Neuropathology at Heidelberg University Hospital to Professor Dr. Dr. Felix Sahm. When Andreas von Deimling was appointed W3 Professor of Neuropathology in 2007, Heidelberg Faculty of Medicine at Heidelberg University, together with the German Cancer Research Center (DKFZ), pursued a strategic […]

read more
Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany Paris and Frankfurt, October 19, 2026. Sanofi today broke ground on a new state-of-the-art insulin manufacturing facility at its BioCampus in Frankfurt, Germany. The new facility will bring a new generation of insulin production to one of Sanofi’s largest integrated research and manufacturing sites, […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp